Eisuke Inoue

8.9k total citations · 1 hit paper
233 papers, 5.5k citations indexed

About

Eisuke Inoue is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Eisuke Inoue has authored 233 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Rheumatology, 42 papers in Pathology and Forensic Medicine and 40 papers in Genetics. Recurrent topics in Eisuke Inoue's work include Rheumatoid Arthritis Research and Therapies (132 papers), Systemic Lupus Erythematosus Research (47 papers) and Chronic Lymphocytic Leukemia Research (39 papers). Eisuke Inoue is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (132 papers), Systemic Lupus Erythematosus Research (47 papers) and Chronic Lymphocytic Leukemia Research (39 papers). Eisuke Inoue collaborates with scholars based in Japan, United States and United Kingdom. Eisuke Inoue's co-authors include Hisashi Yamanaka, Naoyuki Kamatani, Atsuo Taniguchi, Shigeki Momohara, Ayako Nakajima, Taisuke Tomatsu, Eiichi Tanaka, Masako Hara, Katsunori Ikari and Masatoshi Hara and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Eisuke Inoue

220 papers receiving 5.4k citations

Hit Papers

Moving Beyond the Hazard Ratio in Quantifying the Between... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
    2014 421 citations Hajime Uno, Brian Claggett et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eisuke Inoue Japan 39 2.7k 798 791 782 658 233 5.5k
René‐Marc Flipo France 38 2.8k 1.0× 674 0.8× 559 0.7× 798 1.0× 393 0.6× 212 4.7k
Liron Caplan United States 36 2.7k 1.0× 749 0.9× 640 0.8× 797 1.0× 408 0.6× 100 4.5k
Tim Bongartz United States 25 2.1k 0.8× 882 1.1× 576 0.7× 598 0.8× 398 0.6× 45 4.5k
Atsuo Taniguchi Japan 37 2.5k 0.9× 542 0.7× 658 0.8× 609 0.8× 494 0.8× 195 4.1k
Xavier Le Loët France 42 3.3k 1.2× 1.4k 1.7× 617 0.8× 1.3k 1.7× 644 1.0× 198 5.4k
Dario Roccatello Italy 43 3.1k 1.1× 1.3k 1.7× 767 1.0× 1.5k 1.9× 570 0.9× 357 6.8k
Nils Feltelius Sweden 32 2.2k 0.8× 822 1.0× 1.0k 1.3× 801 1.0× 736 1.1× 79 4.1k
Raimón Sanmartí Spain 40 3.6k 1.3× 1.6k 2.0× 418 0.5× 1.3k 1.6× 416 0.6× 263 5.3k
Mahboob U. Rahman United States 38 3.8k 1.4× 1.4k 1.8× 416 0.5× 1.6k 2.1× 912 1.4× 85 5.8k
Benjamín Fernández‐Gutiérrez Spain 36 2.4k 0.9× 1.2k 1.5× 350 0.4× 391 0.5× 685 1.0× 194 4.9k

Countries citing papers authored by Eisuke Inoue

Since Specialization
Citations

This map shows the geographic impact of Eisuke Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisuke Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisuke Inoue more than expected).

Fields of papers citing papers by Eisuke Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eisuke Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisuke Inoue. The network helps show where Eisuke Inoue may publish in the future.

Co-authorship network of co-authors of Eisuke Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Eisuke Inoue. A scholar is included among the top collaborators of Eisuke Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eisuke Inoue. Eisuke Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsushita, Masakazu, Ryoko Sakai, Naoto Yokogawa, et al.. (2025). Prevalence of systemic lupus erythematosus and age-stratified treatment trends in the Japanese population: A cross-sectional study based on the National Database of Health Insurance Claims. Modern Rheumatology. 35(5). 850–858. 2 indexed citations
2.
Miyaji, Yumiko, Kiwako Yamamoto‐Hanada, Kazuo Noguchi, et al.. (2025). Safer oral immunotherapy with very low-dose introduction for pediatric hen’s egg allergy. Journal of Allergy and Clinical Immunology Global. 4(4). 100542–100542.
3.
4.
5.
Hashimoto, Keiji, et al.. (2024). Effects of the abacus-based mental calculation training application “SoroTouch” on cognitive functions: A randomized controlled trial. PLoS ONE. 19(3). e0299201–e0299201. 4 indexed citations
6.
7.
Inoue, Eisuke, Kengo Asada, Wakao Fukuda, et al.. (2023). Recombinase polymerase amplification using novel thermostable strand-displacing DNA polymerases from Aeribacillus pallidus and Geobacillus zalihae. Journal of Bioscience and Bioengineering. 135(4). 282–290. 7 indexed citations
8.
Tanaka, Eiichi, Eisuke Inoue, Rei Yamaguchi, et al.. (2023). Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort. Modern Rheumatology. 34(2). 322–328. 1 indexed citations
9.
Furuya, Takefumi, Eisuke Inoue, Eiichi Tanaka, et al.. (2023). Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Clinical Rheumatology. 43(1). 521–526. 9 indexed citations
10.
Matoba, Ryo, Satoshi Yuki, Manabu Shiozawa, et al.. (2023). The BEETS (JACCRO CC-18) Trial: An Observational and Translational Study of BRAF -Mutated Metastatic Colorectal Cancer. Future Oncology. 19(17). 1165–1174. 2 indexed citations
11.
Higuchi, Tomoyuki, Eiichi Tanaka, Eisuke Inoue, et al.. (2023). AB0286 RETENTION RATE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH DECREASED KIDNEY FUNCTION: RESULTS FROM THE IORRA COHORT. Annals of the Rheumatic Diseases. 82. 1324–1324. 1 indexed citations
12.
Tanaka, Eiichi, Eisuke Inoue, Ayako Shoji, et al.. (2022). Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. PLoS ONE. 17(11). e0277566–e0277566. 3 indexed citations
13.
Nagasawa, Satoi, Yuta Kuze, Ichiro Maeda, et al.. (2021). Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast. Communications Biology. 4(1). 438–438. 36 indexed citations
14.
Kawasaki, Maki, Masako Waguri, Yuichi Sato, et al.. (2021). Protocol for an interventional study to reduce postpartum weight retention in obese mothers using the internet of things and a mobile application: a randomized controlled trial (SpringMom). BMC Pregnancy and Childbirth. 21(1). 582–582. 6 indexed citations
15.
Furuya, Takefumi, Eisuke Inoue, Eiichi Tanaka, et al.. (2020). Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study. SHILAP Revista de lepidopterología. 6(2). 82–87. 6 indexed citations
16.
17.
Uno, Hajime, Brian Claggett, Lü Tian, et al.. (2014). Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis. Journal of Clinical Oncology. 32(22). 2380–2385. 421 indexed citations breakdown →
18.
Momohara, Shigeki, Eisuke Inoue, Katsunori Ikari, et al.. (2011). Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life. Modern Rheumatology. 21(5). 476–481. 23 indexed citations
19.
Furuya, Takefumi, et al.. (2009). Associated factors for falls and fear of falling in Japanese patients with rheumatoid arthritis. Clinical Rheumatology. 28(11). 1325–1330. 59 indexed citations
20.
Tsukahara, S., Minoru Shinozaki, Katsunori Ikari, et al.. (2007). Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients. Lara D. Veeken. 47(1). 41–44. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by René‐Marc Flipo Breakdown of academic impact, for papers by Liron Caplan Breakdown of academic impact, for papers by Tim Bongartz Breakdown of academic impact, for papers by Atsuo Taniguchi Breakdown of academic impact, for papers by Xavier Le Loët Breakdown of academic impact, for papers by Dario Roccatello Breakdown of academic impact, for papers by Nils Feltelius Breakdown of academic impact, for papers by Raimón Sanmartí Breakdown of academic impact, for papers by Mahboob U. Rahman Breakdown of academic impact, for papers by Benjamín Fernández‐Gutiérrez
Rankless by CCL
2026